These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 21468700

  • 1. Expression of chemokine receptor CCR5 correlates with the presence of hepatic molecular metastases in K-ras positive human colorectal cancer.
    Schimanski CC, Moehler M, Gockel I, Zimmermann T, Lang H, Galle PR, Berger MR.
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1139-45. PubMed ID: 21468700
    [Abstract] [Full Text] [Related]

  • 2. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M, Linnemann U, Berger MR.
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [Abstract] [Full Text] [Related]

  • 3. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?
    Conzelmann M, Linnemann U, Berger MR.
    Int J Colorectal Dis; 2005 Mar; 20(2):137-46. PubMed ID: 15459772
    [Abstract] [Full Text] [Related]

  • 4. Modified mismatch polymerase chain reaction-restriction fragment length polymorphism detected mutations in codon 12 and 13 of exon 2 of K-ras gene in colorectal cancer patients and its association with liver metastases: Data from a South Asian country.
    Faleel FD, Zoysa MI, Lokuhetti MD, Gunawardena YI, Chandrasekharan VN, Dassanayake RS.
    J Cancer Res Ther; 2016 Mar; 12(4):1272-1277. PubMed ID: 28169239
    [Abstract] [Full Text] [Related]

  • 5. Detection of disseminated tumour cells in the liver of colorectal cancer patients.
    Conzelmann M, Linnemann U, Berger MR.
    Eur J Surg Oncol; 2005 Feb; 31(1):38-44. PubMed ID: 15642424
    [Abstract] [Full Text] [Related]

  • 6. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
    Mostert B, Jiang Y, Sieuwerts AM, Wang H, Bolt-de Vries J, Biermann K, Kraan J, Lalmahomed Z, van Galen A, de Weerd V, van der Spoel P, Ramírez-Moreno R, Verhoef C, Ijzermans JN, Wang Y, Gratama JW, Foekens JA, Sleijfer S, Martens JW.
    Int J Cancer; 2013 Jul; 133(1):130-41. PubMed ID: 23233388
    [Abstract] [Full Text] [Related]

  • 7. K-ras mutation status correlates with the expression of VEGFR1, VEGFR2, and PDGFRalpha in colorectal cancer.
    Schimanski CC, Zimmermann T, Schmidtmann I, Gockel I, Lang H, Galle PR, Moehler M, Berger MR.
    Int J Colorectal Dis; 2010 Feb; 25(2):181-6. PubMed ID: 19936766
    [Abstract] [Full Text] [Related]

  • 8. Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13.
    Kawamata H, Yamashita K, Kojo K, Ushiku H, Ooki A, Watanabe M.
    Genomics; 2015 Aug; 106(2):71-5. PubMed ID: 26026309
    [Abstract] [Full Text] [Related]

  • 9. Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.
    Kuramochi H, Nakajima G, Kaneko Y, Nakamura A, Inoue Y, Yamamoto M, Hayashi K.
    BMC Cancer; 2012 Mar 13; 12():88. PubMed ID: 22409860
    [Abstract] [Full Text] [Related]

  • 10. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
    Umeda Y, Nagasaka T, Mori Y, Sadamori H, Sun DS, Shinoura S, Yoshida R, Satoh D, Nobuoka D, Utsumi M, Yoshida K, Yagi T, Fujiwara T.
    J Hepatobiliary Pancreat Sci; 2013 Feb 13; 20(2):223-33. PubMed ID: 23010994
    [Abstract] [Full Text] [Related]

  • 11. Low expression of chemokine receptor CCR5 in human colorectal cancer correlates with lymphatic dissemination and reduced CD8+ T-cell infiltration.
    Zimmermann T, Moehler M, Gockel I, Sgourakis GG, Biesterfeld S, Müller M, Berger MR, Lang H, Galle PR, Schimanski CC.
    Int J Colorectal Dis; 2010 Apr 13; 25(4):417-24. PubMed ID: 20054600
    [Abstract] [Full Text] [Related]

  • 12. Mutations of p53 and K-ras correlate TF expression in human colorectal carcinomas: TF downregulation as a marker of poor prognosis.
    Rao B, Gao Y, Huang J, Gao X, Fu X, Huang M, Yao J, Wang J, Li W, Zhang J, Liu H, Wang L, Wang J.
    Int J Colorectal Dis; 2011 May 13; 26(5):593-601. PubMed ID: 21404058
    [Abstract] [Full Text] [Related]

  • 13. Association of folate intake, dietary habits, smoking and COX-2 promotor -765G>C polymorphism with K-ras mutation in patients with colorectal cancer.
    Kamal MM, Youssef OZ, Lotfy AN, Elsaed ET, Fawzy MM.
    J Egypt Natl Canc Inst; 2012 Sep 13; 24(3):115-22. PubMed ID: 22929917
    [Abstract] [Full Text] [Related]

  • 14. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.
    Bokemeyer C, Bondarenko I, Hartmann JT, de Braud F, Schuch G, Zubel A, Celik I, Schlichting M, Koralewski P.
    Ann Oncol; 2011 Jul 13; 22(7):1535-1546. PubMed ID: 21228335
    [Abstract] [Full Text] [Related]

  • 15. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
    Schimanski CC, Linnemann U, Berger MR.
    Cancer Res; 1999 Oct 15; 59(20):5169-75. PubMed ID: 10537293
    [Abstract] [Full Text] [Related]

  • 16. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
    Isella C, Mellano A, Galimi F, Petti C, Capussotti L, De Simone M, Bertotti A, Medico E, Muratore A.
    Ann Surg; 2013 Jun 15; 257(6):1089-95. PubMed ID: 23665971
    [Abstract] [Full Text] [Related]

  • 17. Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer.
    Su N, Xu XY, Chen H, Gao WC, Ruan CP, Wang Q, Sun YP.
    Tohoku J Exp Med; 2010 Dec 15; 222(4):243-50. PubMed ID: 21127395
    [Abstract] [Full Text] [Related]

  • 18. Interlaboratory comparison of K-ras testing by real-time PCR and RFLP in colorectal cancer samples.
    Lanthaler AJ, Spizzo G, Mitterer M, Mian C, Mazzoleni G.
    Diagn Mol Pathol; 2011 Jun 15; 20(2):90-3. PubMed ID: 21532493
    [Abstract] [Full Text] [Related]

  • 19. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
    Bai YQ, Liu XJ, Wang Y, Ge FJ, Zhao CH, Fu YL, Lin L, Xu JM.
    Zhonghua Zhong Liu Za Zhi; 2013 Sep 15; 35(9):666-71. PubMed ID: 24332053
    [Abstract] [Full Text] [Related]

  • 20. Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients.
    Pérez-Ruiz E, Rueda A, Pereda T, Alcaide J, Bautista D, Rivas-Ruiz F, Villatoro R, Pérez D, Redondo M.
    Tumour Biol; 2012 Dec 15; 33(6):1829-35. PubMed ID: 22791568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.